ADO 4.55% 2.1¢ anteotech ltd

Yesterday an expert trio addressed the National Press Club in...

  1. 227 Posts.
    lightbulb Created with Sketch. 137
    Yesterday an expert trio addressed the National Press Club in Canberra to provide a specialist view on COVID-19. Infectious diseases physician Sanjaya Senanayake said it will take six years to vaccinate enough of the world’s population to reduce the threat of COVID-19. Experts say vaccines are not a silver bullet i.e. hygiene measures, masks and COVID-19 testing will be part of life for years to come.

    That being the case, ADO's direct sales channel opportunity (for its own testing kit) combine with its indirect sales channel opportunity (i.e. via partners like Ellume offering testing kits using ADO's technology) to address an enormous global market. I'd love to see ADO inform the market of its Total Available Market (TAM), Serviceable Available Market (SAM) and Serviceable Obtainable Market (SOM).

    We are very close to the AnteoTech COVID-19 Antigen Rapid Test phase 5 milestone (market launch). IMHO, it's time for the company to release a business update - the Lateral Flow Market (LFM) projections would have materially increased since the figures given in the Nov 2020 AGM presentation. Indeed, the company acknowledged (in the AGM presentation) that the impact of COVID-19 will alter the market profile significantly in the next 5 years.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.001(4.55%)
Mkt cap ! $50.57M
Open High Low Value Volume
2.2¢ 2.3¢ 2.1¢ $21.26K 972.7K

Buyers (Bids)

No. Vol. Price($)
26 3457982 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 1104891 1
View Market Depth
Last trade - 16.10pm 30/04/2024 (20 minute delay) ?
Last
2.1¢
  Change
-0.001 ( 4.55 %)
Open High Low Volume
2.2¢ 2.3¢ 2.1¢ 552096
Last updated 13.47pm 30/04/2024 ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.